1) Lentivector Gene Therapy for X-linked Severe Combined Immune Deficiency (XSCID) in Older Children, Young Adults with Impaired Immunity 2) A New Approach to Cancer Immunotherapy Targeting Unique Cancer Mutations

1) Lentivector Gene Therapy for X-linked Severe Combined Immune Deficiency (XSCID) in Older Children, Young Adults with Impaired Immunity 2) A New Approach to Cancer Immunotherapy Targeting Unique Cancer MutationsPresented by: Harry L. Malech, Chief, Laboratory of Host Defenses and Chief, Genetic Immunotherapy Section, NIAID, NIH and Steven A. Rosenberg, MD, PhD, Chief, Surgery Branch, NCI, NIHCategory: Clinical Center Grand RoundsAired date: 09/30/2015
Source: Videocast - All Events - Category: Journals (General) Tags: Past Events Source Type: video